Medical New Way to Get Drugs into the Brain

  • Thread starter Thread starter DigEagle
  • Start date Start date
  • Tags Tags
    Brain Drugs
AI Thread Summary
A new procedure for administering drugs directly into the brain has been developed, with potential implications for treating neurological disorders like Alzheimer's and Parkinson's disease. The method reportedly allows for reversible opening of the blood-brain barrier for a few hours, raising concerns about the risk of harmful substances entering the brain during that time. The lack of specificity means that while therapeutic drugs can cross the barrier, so can microbes, posing risks such as meningitis. The discussion highlights skepticism about the practical applications of this technique for conditions like Alzheimer's and Parkinson's, suggesting it may be more beneficial in experimental settings rather than clinical ones. Additionally, the challenge of ensuring that toxic metabolic products of drugs can exit the brain is emphasized, indicating that simply getting drugs into the brain is only part of the solution. Overall, while the technique is innovative, its clinical utility remains uncertain.
DigEagle
Messages
5
Reaction score
0
Hey everyone,

I found this really interesting article at Technology Review about a new procedure scientists have developed for administering drugs directly into the brain. This could potentially have major implications for the treatment of such neurological disorders as Alzheimer's and Parkinson's disease. You can check out the full article here:

http://www.technologyreview.com/read_article.aspx?id=16982&ch=biotech
 
Biology news on Phys.org
Pretty interesting. I'd have expected something like that to have the effect of a sledge-hammer, so was surprised to see that they're saying it's reversible, and within only a few hours.
 
I would be a little bit scared knowing that my blood-brain barrier would be open for 4 hours, that's a lot of time for nasty things to get in there. Also assuming that a single-administration of the drug probably will not do, it would mean that the barrier will be opened up multiple times. It's a cool approach, though, I would be interested to see what actual applications come out of it.
 
muadib2k said:
I would be a little bit scared knowing that my blood-brain barrier would be open for 4 hours, that's a lot of time for nasty things to get in there.
Yes, that's certainly a major limitation. There's no specificity, so while your drug can get across, so can microbes. I'd have to wonder what disease is so severe that one would consider worth the risk of meningitis an acceptable possible side effect of the treatment, unless you were actually treating meningitis or another brain infection of some sort. Getting antibiotics across the blood-brain barrier is really difficult, so only a few are available that are effective for this. If you happen to have an infection with something resistant to those (perhaps as the result of a trauma or surgical complication), getting an alternative antibiotic across the blood-brain barrier seems worth this risk.

Also assuming that a single-administration of the drug probably will not do, it would mean that the barrier will be opened up multiple times. It's a cool approach, though, I would be interested to see what actual applications come out of it.

I'd be curious too. It may have more applicability in an experimental setting than a clinical setting, where a response to a single administration of a drug may be all that you want to test (and not necessarily in humans), then leave it to the biochemists and pharmacologists to figure out how to get it across an intact blood-brain barrier later, when it's demonstrated the drug actually will do what it's supposed to once across.

I don't know what application it could possibly have for Parkinson's or Alzheimer's other than people like to toss those out as examples every time there's a new technology available even when it really won't help with them because those are familiar to most people.
 
It may have more applicability in an experimental setting than a clinical setting, where a response to a single administration of a drug may be all that you want to test (and not necessarily in humans), then leave it to the biochemists and pharmacologists to figure out how to get it across an intact blood-brain barrier later...

Thats a really good point, and I can see this technique being used in order to elucidate the efficacy and potency of various drugs in vivo. However, with that said, when dealing with drugs you also have to consider their metabolic products. In many instances drugs get broken down to compounds that are very toxic and may do more harm if not eliminated rapidly from the body. The way I see it, getting a drug into the brain is only half the battle; you would have to ensure its metabolite(s) can also get out. It would be hard enough to make a drug that can easily cross the barrier and whose metabolic product can leave.

But I totally agree with you on this technique being more useful in a experimental setting and not clinical, at least for now.
 
Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S. According to articles in the Los Angeles Times, "Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S.", and "Kissing bugs bring deadly disease to California". LA Times requires a subscription. Related article -...
I am reading Nicholas Wade's book A Troublesome Inheritance. Please let's not make this thread a critique about the merits or demerits of the book. This thread is my attempt to understanding the evidence that Natural Selection in the human genome was recent and regional. On Page 103 of A Troublesome Inheritance, Wade writes the following: "The regional nature of selection was first made evident in a genomewide scan undertaken by Jonathan Pritchard, a population geneticist at the...
I use ethanol for cleaning glassware and resin 3D prints. The glassware is sometimes used for food. If possible, I'd prefer to only keep one grade of ethanol on hand. I've made sugar mash, but that is hardly the least expensive feedstock for ethanol. I had given some thought to using wheat flour, and for this I would need a source for amylase enzyme (relevant data, but not the core question). I am now considering animal feed that I have access to for 20 cents per pound. This is a...

Similar threads

Replies
1
Views
2K
Replies
3
Views
6K
Replies
6
Views
6K
Replies
3
Views
3K
Replies
8
Views
5K
Replies
2
Views
4K
Replies
3
Views
3K
Back
Top